Journal ArticleOPEN ACCESS

Efavirenz as a cholesterol‐targeting drug for AD

  • Pikuleva I
Alzheimer's & Dementia (2020) 16(S3)
DOI: 10.1002/alz.040603
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Cytochrome P450 46A1 (CYP46A1) is the CNS-specific cholesterol 24

Cite

CITATION STYLE

APA

Pikuleva, I. A. (2020). Efavirenz as a cholesterol‐targeting drug for AD. Alzheimer’s & Dementia, 16(S3). https://doi.org/10.1002/alz.040603

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free